You just read:

Nordic Nanovector: Updated Results From Phase 1/2 Trial of Betalutin® in Non-Hodgkin Lymphoma to be Presented at ASH in December

News provided by

Nordic Nanovector

01 Nov, 2017, 13:33 GMT